{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:soluble-guanylate-cyclase-stimulators",
  "owner": "cardio",
  "kind": "drug",
  "slug": "soluble-guanylate-cyclase-stimulators",
  "name": "Soluble guanylate cyclase stimulators",
  "aliases": [
    "Soluble Guanylate Cyclase Stimulator",
    "Guanylate Cyclase Stimulators",
    "sGC stimulators"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Soluble guanylate cyclase (sGC) stimulators are medicines that act on soluble guanylate cyclase, an enzyme that the Adempas label calls the receptor for nitric oxide. The US label of Adempas (riociguat) calls it an sGC stimulator indicated for two kinds of pulmonary hypertension in adults, and the US label of Verquvo (vericiguat) calls it an sGC stimulator indicated for chronic heart failure. Both medicines have their own pages. This is the class page.",
  "summary_technical": "Class page. MeSH has no descriptor for the class: an exact-label lookup for the descriptor returned an empty list on 2026-11-18, so the identifiers list is empty. RxClass lists the established pharmacologic class on US drug labels Soluble Guanylate Cyclase Stimulator (EPC) for riociguat and for vericiguat, and the mechanism-of-action class Guanylate Cyclase Stimulators for riociguat (read 2026-11-18); both are filed under this page on that evidence. The Adempas label (NDA204819; effective 2026-08-13) and the Verquvo label (NDA214377; effective 2026-01-21) each use the class name in their first indication sentence. The two labels list different conditions. No trial result, dose or instruction is recorded.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-18",
  "last_evidence_check": "2026-11-18",
  "next_review_due": "2027-05-18",
  "identifiers": [],
  "navigation": {
    "cardio": {
      "system": [
        "blood-vessels",
        "heart"
      ],
      "condition-area": [
        "coronary-and-vascular-disease"
      ]
    }
  },
  "payload": {
    "level": "class",
    "mechanism": "The Adempas label says riociguat stimulates soluble guanylate cyclase, an enzyme in the cardiopulmonary system and the receptor for nitric oxide."
  },
  "content_digest": "d666ee0a27400a4cffeaadcecd073a866e94ca1c18173e91d423a559495bcb4a",
  "review": {
    "content_digest": "d666ee0a27400a4cffeaadcecd073a866e94ca1c18173e91d423a559495bcb4a",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "The Adempas label lists chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension as indications",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:pulmonary-hypertension",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "The Adempas label lists pulmonary arterial hypertension as an indication",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:pulmonary-arterial-hypertension",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "The Verquvo label lists chronic heart failure as the indication",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:heart-failure",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:riociguat",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-1439816-2026-11-18",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:vericiguat",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-2475830-2026-11-18",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/soluble-guanylate-cyclase-stimulators/",
  "context_path": "api/v1/context/cardio--soluble-guanylate-cyclase-stimulators.md"
}
